Parkinson's disease (PD) is a progressive, neurodegenerative disorder that primarily affects motor function, due to the loss of dopamine-producing cells in the substantia nigra. Understanding its pathophysiology, clinical presentation, diagnosis, and management is crucial for medical professionals.
The hallmark of PD is the degeneration of dopamine-producing neurons within the substantia nigra, leading to a decrease in striatal dopamine levels. This imbalance affects the normal functioning of the basal ganglia circuitry, resulting in the characteristic motor symptoms of PD.
The cardinal symptoms of PD include resting tremor, rigidity, bradykinesia, and postural instability. Non-motor symptoms such as cognitive impairment, mood disorders, sleep disturbances, and autonomic dysfunction can also occur, often preceding motor symptoms by years.
Diagnosis of PD is primarily clinical, based on the presence of characteristic motor symptoms and response to dopaminergic therapy. Neuroimaging techniques such as DaTscan can support the diagnosis but are not routinely used due to their high cost and limited availability.
Management of PD is symptomatic, with the primary aim to improve quality of life. Pharmacological treatment mainly involves dopamine replacement therapies. Non-pharmacological interventions include physical therapy, occupational therapy, and in advanced cases, deep brain stimulation.
PD is a complex neurodegenerative disorder with a multifaceted clinical presentation. A comprehensive understanding of its pathophysiology, clinical features, diagnosis, and management strategies is essential for optimal patient care. As medical professionals, we must stay abreast of the latest research developments to provide the best possible care to our patients with PD.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation